Coupling between brevifoliol (I) and β-lactam (2) yielded, after protecting group removal, brevifoliol 13-[N-benzoyl-(2'R,3'S)-3'-phenylisoserinate] (3). This novel taxol analogue was found to be inactive in the microtubule binding assay and had little cytotoxicity against B16 melanoma cells.